CompletedPhase 2

Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders

United States55 participantsStarted 2013-05

Plain-language summary

The purpose of this study is to determine whether choline supplementation can improve cognitive functioning of children with prenatal alcohol exposure.

Who can participate

Age range5 Years – 10 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Confirmed histories of prenatal alcohol exposure (by review of medical, legal, or social service records or maternal report, if available; information about levels and timing of exposure will be inquired, but not necessary for inclusion) * English as primary language Exclusion Criteria: * Significant physical (e.g., uncorrected visual impairment, hemiparesis) or psychiatric (e.g., psychosis) disability that would prohibit participation * History of neurological condition (e.g., epilepsy)

What they're measuring

Changes in cognitive function as measured by performance on neuropsychological tasks of learning/memory, executive functions, and attention

Timeframe: Baseline and 6 weeks

Trial details

NCT IDNCT01911299

SponsorSan Diego State University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-05

View on ClinicalTrials.gov More Fetal Alcohol Spectrum Disorders trials